BASF Unveils Nemasphere™ for SCN Management

Key Highlights:

  • Nemasphere™ offers unparalleled SCN resistance, the first biotechnology trait for SCN.

  • Nemasphere™ stacks with Enlist E3® technology for top-performing soybean seed varieties.

  • Boosts yield potential by 8% on average in over 200 field trials.

  • Pending regulatory approval, Nemasphere™ expected to be available in 2028.

  • First novel mode of action against SCN in over 60 years.

Source (Direct)

Notable Quote:

BASF is committed to helping farmers doing the Biggest Job on Earth through innovation and bringing impactful solutions to market. We are thrilled to unveil Nemasphere, an innovation that will become the new standard of nematode management.”

Scott Kay, Vice President of U.S. Agricultural Solutions at BASF

Our Take:

Nemasphere™ represents a significant breakthrough in agricultural biotechnology, addressing a critical need in soybean farming. With soybean cyst nematode being the leading cause of yield loss in the United States, BASF’s innovative solution not only promises enhanced resistance but also integrates seamlessly with existing high-yield soybean seed varieties. This advancement is set to redefine nematode management, providing farmers with a reliable, effective tool to combat yield loss and optimize their harvests. The strategic partnership with Corteva Agriscience and M.S. Technologies further underscores the collaborative effort to bring this pioneering trait to market, marking a new era in sustainable agricultural practices.